本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Praxis Precision Medicines, Inc.

50.54
+0.24000.48%
盤後50.540.00000.00%18:49 EDT
成交量:29.80萬
成交額:1,501.82萬
市值:10.29億
市盈率:-4.68
高:51.38
開:50.19
低:49.60
收:50.30
資料載入中...
2025/06/27

重要事件披露

Form 8-K - Current report
2025/05/02

重要事件披露

Form 8-K - Current report
2025/05/02

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/02

重要事件披露

Form 8-K - Current report
2025/02/28

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/02/28

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/02/28

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/28

重要事件披露

Form 8-K - Current report
2025/01/29

重要事件披露

Form 8-K - Current report
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/12

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/06

重要事件披露

Form 8-K - Current report